Search results for "psychotropic drug"

showing 10 items of 65 documents

Analysis of psychoactive substances in water by information dependent acquisition on a hybrid quadrupole time-of-flight mass spectrometer.

2016

Emerging drugs of abuse, belonging to many different chemical classes, are attracting users with promises of “legal” highs and easy access via internet. Prevalence of their consumption and abuse through wastewater-based epidemiology can only be realized if a suitable analytical screening procedure exists to detect and quantify them in water. Solid-phase extraction and ultra-high performance liquid chromatography quadrupole time-of-flight-mass spectrometry (UHPLC–QqTOF–MS/MS) was applied for rapid suspect screening as well as for the quantitative determination of 42 illicit drugs and metabolites in water. Using this platform, we were able to identify amphetamines, tryptamines, piperazines, p…

010501 environmental sciencesWastewaterMass spectrometryTandem mass spectrometry01 natural sciencesBiochemistryRiver waterHigh resolution mass spectrometryAnalytical ChemistryRiversTandem Mass SpectrometryQuantificationPsychoactive drugsHumansSample preparationSolid phase extractionQuadrupole time of flightChromatography High Pressure Liquid0105 earth and related environmental sciencesPsychotropic DrugsChromatographyChemistryIllicit Drugs010401 analytical chemistryOrganic ChemistrySolid Phase ExtractionWaterGeneral MedicineQuantitative determination0104 chemical sciencesWastewaterEnvironmental chemistryScreeningDatabases ChemicalWater Pollutants ChemicalJournal of chromatography. A
researchProduct

Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation an…

2020

Background/Objective Patients with non-small cell lung cancer (NSCLC) develop resistance to antitumor agents by mechanisms that involve the epithelial-to-mesenchymal transition (EMT). This necessitates the development of new complementary drugs, e.g., cannabinoid receptors (CB1 and CB2) agonists including tetrahydrocannabinol (THC) and cannabidiol (CBD). The combined use of THC and CBD confers greater benefits, as CBD enhances the effects of THC and reduces its psychotropic activity. We assessed the relationship between the expression levels of CB1 and CB2 to the clinical features of a cohort of patients with NSCLC, and the effect of THC and CBD (individually and in combination) on prolifer…

0301 basic medicineMaleCannabinoid receptorLung NeoplasmsPulmonologymedicine.medical_treatmentGene ExpressionBiochemistryLung and Intrathoracic TumorsReceptor Cannabinoid CB20302 clinical medicineContractile ProteinsReceptor Cannabinoid CB1Epidermal growth factorCarcinoma Non-Small-Cell LungMedicine and Health SciencesCannabidiolDronabinolAged 80 and overMultidisciplinaryChemistryQRDrugsMiddle AgedCancer Cell MigrationCell MotilityOncologyCell Processes030220 oncology & carcinogenesisMedicinelipids (amino acids peptides and proteins)Femalemedicine.drugResearch ArticleAdultEpithelial-Mesenchymal TransitionScienceChronic Obstructive Pulmonary DiseaseCell Migration03 medical and health sciencesCell Line Tumormental disordersmedicineGeneticsHumansEpithelial–mesenchymal transitionTetrahydrocannabinolCell ProliferationAgedA549 cellPharmacologyCannabinoid Receptor AgonistsPsychotropic DrugsCell growthCannabinoidsorganic chemicalsCancers and NeoplasmsBiology and Life SciencesProteinsCell Biologydigestive system diseasesActinsrespiratory tract diseasesNon-Small Cell Lung CancerCytoskeletal Proteins030104 developmental biologyA549 CellsCancer researchCannabinoidCannabidiolDevelopmental BiologyPLoS ONE
researchProduct

Indomethacin blocks the increased conditioned rewarding effects of cocaine induced by repeated social defeat

2018

It is well established that repeated social defeat stress can induce negative long-term consequences such as increased anxiety-like behavior and enhances the reinforcing effect of psychostimulants in rodents. In the current study, we evaluated how the immune system may play a role in these long-term effects of stress. A total of 148 OF1 mice were divided into different experimental groups according to stress condition (exploration or social defeat) and pre-treatment (saline, 5 or 10 mg/kg of the anti-inflammatory indomethacin) before each social defeat or exploration episode. Three weeks after the last social defeat, anxiety was evaluated using an elevated plus maze paradigm. After this tes…

0301 basic medicinePhysiologyIndomethacinSocial SciencesAnxietyPathology and Laboratory MedicineHippocampusMiceRandom Allocation0302 clinical medicineCocaineImmune PhysiologyConditioning PsychologicalMedicine and Health SciencesPsychologyImmune ResponseMammalsInnate Immune SystemMultidisciplinaryAnimal BehaviorQAnti-Inflammatory Agents Non-SteroidalREukaryotaBrainChemistryPsicobiologiaBehavioral PharmacologyAnimal SocialityPhysical SciencesVertebratesCytokinesMedicineAnatomyResearch ArticleDominance-SubordinationScienceImmunologyPsychological StressRodentsCocaine-Related Disorders03 medical and health sciencesAlkaloidsSigns and SymptomsRewardDiagnostic MedicineRecreational Drug UseMental Health and PsychiatryAnimalsPharmacologyInflammationBehaviorPsychotropic DrugsInterleukin-6Chemical CompoundsOrganismsBiology and Life SciencesCorrectionMolecular Development030104 developmental biologyImmune SystemAmniotesExploratory BehaviorZoologyStress Psychological030217 neurology & neurosurgeryDevelopmental Biology
researchProduct

Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons.

2012

Background Surgeons are usually exposed to high workloads leading to fatigue and stress. This not only increases the likelihood of mistakes during surgery but also puts pressure on surgeons to use drugs to counteract fatigue, distress, concentration deficits, burnout or symptoms of depression. The prevalence of surgeons taking pharmacological cognitive enhancement (CE) or mood enhancement (ME) drugs has not been systematically assessed so far. Methods Surgeons who attended five international conferences in 2011 were surveyed with an anonymous self-report questionnaire (AQ) regarding the use of prescription or illicit drugs for CE and ME and factors associated with their use. The Randomized …

AdultAged 80 and overMalePsychotropic DrugsPrescription DrugsIllicit DrugsMiddle AgedDrug UtilizationYoung AdultPhysiciansSurveys and QuestionnairesHumansSurgeon(s)FemalePrescription drug(s)Nootropic AgentsStimulant(s)AgedResearch ArticleCognitive enhancementBMC medicine
researchProduct

CYP2D6 genotype and phenotyping by determination of dextromethorphan and metabolites in serum of healthy controls and of patients under psychotropic …

1998

Fourteen drug free healthy volunteers and 22 psychiatric patients under psychotropic medication were phenotyped for their individual CYP2D6 activity using dextromethorphan as a probe drug. A solution containing 20 mg dextromethorphan was administered and blood was taken 60 min later for determination of dextromethorphan and metabolites in serum. For comparison, urine was collected over 8 h after ingestion of 20 mg dextromethorphan in a separate test. The CYP2D6 phenotype was determined from the ratio of dextromethorphan to dextrorphan. For genotyping, mutant alleles of the CYP2D6 gene were identified using allele-specific polymerase chain reactions. Genotyping revealed five poor metabolizer…

AdultMaleCYP2D6animal structuresGenotypeMetaboliteUrineBiologyPharmacologyDextromethorphandigestive systemchemistry.chemical_compoundDextrorphanMoclobemideGeneticsmedicineHumansGeneral Pharmacology Toxicology and Pharmaceuticsskin and connective tissue diseasesGenotypingPsychotropic DrugsDextromethorphanMiddle AgedPhenotypeCytochrome P-450 CYP2D6chemistryFemalePharmacogeneticsmedicine.drugPharmacogenetics
researchProduct

Public Opinion on Psychotropic Drugs: An Analysis of the Factors Influencing Acceptance or Rejection

1997

Widespread negative attitudes and irrational beliefs about psychotropic drugs held by the public affect patients' treatment compliance. This study was an attempt to identify factors influencing people's acceptance or rejection of psychotropic drugs. An opinion poll was taken by a representative group of 2,176 adults in Germany. In addition to their attitudes toward psychotropic and cardiac drugs and their ratings of perceived risks and benefits, they were also asked about their drug knowledge, their fear of losing self-control, and their fundamental political values. Our results show that even for the treatment of severe mental disease, psychotropic drugs generally are not well accepted com…

AdultMaleDrugHealth Knowledge Attitudes Practicemedicine.medical_specialtyAdolescentmedia_common.quotation_subjectAffect (psychology)Public opinionPharmacotherapyPatient Education as TopicGermanymedicineHumansMass MediaPsychiatryHealth EducationBiological Psychiatrymedia_commonPsychotropic Drugsbusiness.industrySocial perceptionMental DisordersPublic healthPoliticsDiscriminant AnalysisCardiovascular AgentsPsychotherapyPsychiatry and Mental healthCardiovascular DiseasesPatient SatisfactionPublic OpinionPatient ComplianceFemaleHealth educationBiological psychiatrybusinessAttitude to HealthThe Journal of Nervous &amp Mental Disease
researchProduct

Sequential treatment of ADHD in mother and child (AIMAC study): importance of the treatment phases for intervention success in a randomized trial

2018

Abstract Background The efficacy of parent-child training (PCT) regarding child symptoms may be reduced if the mother has attention-deficit/hyperactivity disorder (ADHD). The AIMAC study (ADHD in Mothers and Children) aimed to compensate for the deteriorating effect of parental psychopathology by treating the mother (Step 1) before the beginning of PCT (Step 2). This secondary analysis was particularly concerned with the additional effect of the Step 2 PCT on child symptoms after the Step 1 treatment. Methods The analysis included 143 mothers and children (aged 6–12 years) both diagnosed with ADHD. The study design was a two-stage, two-arm parallel group trial (Step 1 treatment group [TG]: …

AdultMalePediatricsmedicine.medical_specialtyEfficacylcsh:RC435-571610Motherslaw.inventionTreatment and control groups03 medical and health sciences0302 clinical medicinePharmacotherapy610 Medical sciences MedicineRandomized controlled trialChild of Impaired ParentslawIntervention (counseling)lcsh:PsychiatryMedicineHumans0501 psychology and cognitive sciencesddc:610ChildChildrenProblem BehaviorPsychiatric Status Rating ScalesPsychotropic Drugsbusiness.industryParent training05 social sciencesTreatment phasesAdult treatmentSequential treatmentCombined Modality Therapy3. Good healthPsychotherapyPsychiatry and Mental healthTreatment OutcomeAttention Deficit Disorder with HyperactivityParent trainingParental psychopathologyFemalebusiness030217 neurology & neurosurgery050104 developmental & child psychologyResearch Article
researchProduct

Cumyl-PEGACLONE: A comparatively safe new synthetic cannabinoid receptor agonist entering the NPS market?

2018

AdultMalePharmaceutical SciencePharmacology01 natural sciencesAnalytical ChemistryDesigner Drugs03 medical and health sciencesYoung Adult0302 clinical medicineEnvironmental ChemistryMedicineHumans030216 legal & forensic medicineSpectroscopyCannabinoid Receptor AgonistsPsychotropic Drugsbusiness.industryIllicit Drugs010401 analytical chemistrySynthetic cannabinoid receptor agonistMiddle Aged0104 chemical sciencesSubstance Abuse DetectionSubstance Abuse DetectionFemalebusinessCarbolinesDrug testing and analysis
researchProduct

Experience of Psychotropic Medication -An Interview Study of Persons with Psychosis.

2016

Psychotropic drugs, particularly antipsychotic types, are a cornerstone of the treatment of people with psychosis. Despite numerous studies showing that drug treatment with psychotropic drugs initially alleviates psychiatric symptoms, the proportion of people with mental health problems and symptoms that do not follow doctors' prescriptions, thus exhibiting so-called non-adherence, is considerable. Non-adherence is predominantly seen as a clinical feature and as a patient characteristic that is especially due to patients' poor understanding that they are ill. There is also a widespread notion that non-adherence is of great disadvantage to the patient. This article is based on interviews wit…

AdultMalePsychosismedicine.medical_specialtymedicine.medical_treatmentMedication adherencePsychotropic medicationMedication Adherence03 medical and health sciencesDrug treatmentYoung Adult0302 clinical medicinemedicineHumans030212 general & internal medicineYoung adultPatient participationAntipsychoticPsychiatryAgedPsychotropic Drugsbusiness.industryPatient PreferenceMiddle Agedmedicine.disease030227 psychiatryPsychotic DisordersInterview studyFemalePshychiatric Mental HealthPatient ParticipationbusinessClinical psychologyIssues in mental health nursing
researchProduct

S-Ketamine-Induced NMDA Receptor Blockade during Natural Speech Production and Its Implications for Formal Thought Disorder in Schizophrenia: A Pharm…

2017

Structural and functional changes in the lateral temporal language areas have been related to formal thought disorder (FTD) in schizophrenia. Continuous, natural speech production activates the right lateral temporal lobe in schizophrenia, as opposed to the left in healthy subjects. Positive and negative FTD can be elicited in healthy subjects by glutamatergic NMDA blockade with ketamine. It is unclear whether the glutamate system is related to the reversed hemispheric lateralization during speaking in patients. In a double-blind, crossover, placebo-controlled study, 15 healthy, male, right-handed volunteers overtly described 7 pictures for 3 min each while BOLD signal changes were acquired…

AdultMaleSpeech productionmedicine.medical_specialtyAudiologyReceptors N-Methyl-D-AspartateBrain mappingPsychoses Substance-InducedLateralization of brain functionTemporal lobeThinking03 medical and health sciencesGlutamatergic0302 clinical medicineDouble-Blind Methodmental disordersmedicineHumansSpeechPsychiatryPharmacologyBrain MappingPsychotropic DrugsCross-Over StudiesThought disorderBrainmedicine.diseaseMagnetic Resonance Imaging030227 psychiatryOxygenPsychiatry and Mental healthSchizophreniaCerebrovascular CirculationVisual PerceptionNMDA receptorKetamineSchizophrenic PsychologyOriginal Articlemedicine.symptomPsychologyExcitatory Amino Acid Antagonists030217 neurology & neurosurgeryNeuropsychopharmacology
researchProduct